Immuno-Oncology 360°

The 6th annual IO360° Summit is the premier meeting across all stakeholders in IO, addressing the rapid advancements of clinical, scientific and business developments of IO in one setting to help develop therapeutics for a wider range of cancers at an accelerated rate.
The 3 day summit features more than 80 time sensitive IO topics, over 500 senior level thought leaders and includes over 10 hours of networking.

The 6th Annual Immuno-Oncology 360° Delivers Three Key Benefits:
- Access to KOLs driving the science
- Partnership opportunities with the conference partnering app with all stakeholders in IO
- Presentations on the latest data affecting the science, clinical and business advancements in IO

New for 2020:
- Cell and Gene Therapy Day - A full day on February 27th dedicated to Cell and Gene Therapy for Solid Tumors. Chaired by Dr Aiman Shalabi, GSK.
Keynotes, Cornerstone and Noteable Speakers include Dr Carl June, UPenn, Dr Crystal Mackall, Stanford University, Dr Arie Belldegrun, Allogene, Dr Peter Marks, FDA, Dr Stephanie Goff, NCI, amongst many more.
- Cancer Immunotherapy Debates - This new stye of presentation for IO360° features counterpoint views from leading experts on current controversial clinical issues in IO. Two experts will present the argument and counter-argument in support of two different points of view related to the topic at hand. Debates are
sprinkled throughout the agenda over the course of the 3 days.

2020 Plenary Topics
- Discovery/Preclinical Science
- Imaging Aspects
- Clinical Operations
- Bispecifics
- Business Developments
- Translational Science
- Emerging Biomarkers
- IO Novel Technologies
- AI and Machine Learning
- Clinical Developments

Others Details

Time: 8:00 am to 4:00 pm Speakers: Andrew Baum, MD, Tara Arvedson, PhD, Priti Hegde, PhD, Matthew Albert, MD, PhD, Jeff Allen, PhD, Roy Baynes, MD, PhD, Arie Belldegrun, MD, FACS and many more.